The most sophisticated silk-based tissue scaffold solutions in the world
Serica—on the verge of achieving one of the most elusive and sought after goals in orthopaedic sports medicine—the first off-the-shelf ACL replacement graft offering rapid return to pre-trauma activity levels while regenerating the patient’s own ligament tissue.
Serica has built its product platform on the first and only technology of its kind with a whole new class of biomaterials.
- Natural
- Non-mammalian
- Mechanically superior
- Tailorable bioresorption
- Customizable physical properties for porosity, contouring and texture
- Effective as both a scaffold implant and injectable gel
- Available off of the shelf without hydration or preparation
- Competitive cost structures to address diverse market opportunities
FDA Disclaimer: The Serica Product Portfolio is currently in development and has not been approved or reviewed by the FDA or internationally. The clinical effectiveness of these devices has not yet been demonstrated. Products currently in development are not available for commercial sale.
|